Related Experiment Videos
Resolution of the B cell-positive crossmatch by a modified flow cytometric procedure
T J Farley1, T C Shanahan, W R Bartholomew
1Department of Microbiology and Immunology, State University of New York, Buffalo.
Transplantation
|September 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Distinct effect of retroviral-mediated IFN-alpha gene transfer on human erythroleukemic and CD34+ cell growth and differentiation.
Journal of hematotherapy & stem cell research·2000
Adenovirus and retrovirus mediated interferon alpha gene transfer into CD34+ cells maintains regeneration capacity and enhances adhesion molecules in K562 cells.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research·1999
Clonal dissemination of vancomycin-resistant Enterococci and comparison of susceptibility testing methods.
Diagnostic microbiology and infectious disease·1998
An intralaboratory quality control program for quantitation of CD34+ cells by flow cytometry.
Journal of hematotherapy·1997
Unicentric Castleman disease presenting as hyperenhancing mediastinal mass: A case series diagnosed by linear endobronchial ultrasound guided mediastinal nodal biopsy.
Lung India : official organ of Indian Chest Society·2026
Investigation of IgM Monoclonal Paraprotein in Bone Marrow Aspiration: The Role of Immunophenotyping by Flow Cytometry in Selecting Cases for Molecular Testing for the p.MYD88 L265P Point Mutation.
International journal of laboratory hematology·2026
Phenomenology of a Biographical Disruption: Delirium in the Critically Ill Patient.
Journal of evaluation in clinical practice·2026
Multiplex immunofluorescence in the identification of immune cell compositions in rejection, bronchus-associated lymphoid tissue, and infection in lung allograft tissue.
Virchows Archiv : an international journal of pathology·2026
CD74 in hematological malignancies: from MHC chaperone to therapeutic target.
Leukemia & lymphoma·2026